Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

  1. Yoshino, T.
  2. Di Bartolomeo, M.
  3. Raghav, K.
  4. Masuishi, T.
  5. Loupakis, F.
  6. Kawakami, H.
  7. Yamaguchi, K.
  8. Nishina, T.
  9. Wainberg, Z.
  10. Elez, E.
  11. Rodriguez, J.
  12. Fakih, M.
  13. Ciardiello, F.
  14. Saxena, K.
  15. Kobayashi, K.
  16. Bako, E.
  17. Okuda, Y.
  18. Meinhardt, G.
  19. Grothey, A.
  20. Siena, S.
  21. Di Bartolomeo, M.
Journal:
Nature Communications

ISSN: 2041-1723

Year of publication: 2023

Volume: 14

Issue: 1

Type: Article

DOI: 10.1038/S41467-023-38032-4 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus